Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 931 AL 945

Tauopathy in AD: Therapeutic Potential of MARK-4

Mumtaz, Ahmed F, Rabbani SA, El-Tanani M, Najmi AK, Ali J, Khan MA.

Curr Alzheimer Res. 2024;21(11):779-790. doi: 10.2174/0115672050358397250126151707.

Exploring the potential mechanism of Polygonatum sibiricum for Alzheimer's disease based on network pharmacology and molecular docking: An observational study

Luo L, Pan Y, Chen F, Zhang Z.

Medicine (Baltimore). 2024 Dec 27;103(52):e40726. doi: 10.1097/MD.0000000000040726.

Relation between Apolipoprotein E in Alzheimer's Disease and SARS-CoV-2 and their Treatment Strategy: A Review

Ramachandran AK, Das S, Shenoy GG, Mudgal J, Joseph A.

CNS Neurol Disord Drug Targets. 2024;23(1):9-20. doi: 10.2174/1871527322666221226145141.

Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta-analysis

Nham T, Garcia MC, Tsang KJ, Silva JM, Schneider T, Deng J, Lohit S, Mbuagbaw L, Holbrook A.

J Am Geriatr Soc. 2024 Aug;72(8):2552-2565. doi: 10.1111/jgs.18909. Epub 2024 Apr 5.

Lithium Therapy's Potential to Lower Dementia Risk and the Prevalence of Alzheimer's Disease: A Meta-Analysis

Lu Q, Lv H, Liu X, Zang L, Zhang Y, Meng Q.

Eur Neurol. 2024;87(2):93-104. doi: 10.1159/000538846. Epub 2024 Apr 24.

Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry

Ray NR, Kunkle BW, Hamilton-Nelson K, Kurup JT, Rajabli F, Qiao M, Vardarajan BN, Cosacak MI, Kizil C, Jean-Francois M, Cuccaro M, Reyes-Dumeyer D, Cantwell L, Kuzma A, Vance JM, Gao S, Hendrie HC, Baiyewu O, Ogunniyi A, Akinyemi RO; Alzheimer's Disease Genetics Consortium; Lee WP, Martin ER, Wang LS, Beecham GW, Bush WS, Xu W, Jin F, Wang L, Farrer LA, Haines JL, Byrd GS, Schellenberg GD, Mayeux R, Pericak-Vance MA, Reitz C.

Alzheimers Dement. 2024 Aug;20(8):5247-5261. doi: 10.1002/alz.13880. Epub 2024 Jul 3.

Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value

Sato K, Niimi Y, Ihara R, Iwata A, Iwatsubo T.

J Alzheimers Dis. 2024;101(4):1127-1132. doi: 10.3233/JAD-240623.

Drug Repurposing for Effective Alzheimer's Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches

Roberts JA, Varma VR, Jones A, Thambisetty M.

J Alzheimers Dis. 2024;101(s1):S299-S315. doi: 10.3233/JAD-240680.

Neuropsychiatric Manifestations in Alzheimer's Disease Patients: Genetics and Treatment Options

Singh AK, Malviya R, Prakash A, Verma S.

CNS Neurol Disord Drug Targets. 2024;23(1):39-54. doi: 10.2174/1871527322666230301111216.

Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration

Sutton SS, Magagnoli J, Cummings TH, Hardin JW, Ambati J.

JAMA Ophthalmol. 2024 Feb 1;142(2):108-114. doi: 10.1001/jamaophthalmol.2023.6014.

Nanotechnology in the diagnostic and therapy for Alzheimer's disease

Panghal A, Flora SJS.

Biochim Biophys Acta Gen Subj. 2024 Mar;1868(3):130559. doi: 10.1016/j.bbagen.2024.130559. Epub 2024 Jan 6.

Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer's disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study

Kim YJ, So KY, Lee HM, Hahn C, Song SH, Lee YS, Kim SW, Park HC, Ryu J, Lee JS, Kang MJ, Kim J, Lee Y, Lee JH.

BMC Public Health. 2024 Jan 12;24(1):168. doi: 10.1186/s12889-024-17671-2.

Recent trends in treatment strategies for Alzheimer(')s disease and the challenges: A topical advancement

Liu N, Liang X, Chen Y, Xie L.

Ageing Res Rev. 2024 Feb;94:102199. doi: 10.1016/j.arr.2024.102199. Epub 2024 Jan 15.

Role of Imaging Genetics in Alzheimer's Disease: A Systematic Review and Current Update

Chhetri A, Goel K, Ludhiadch A, Singh P, Munshi A.

CNS Neurol Disord Drug Targets. 2024;23(9):1143-1156. doi: 10.2174/0118715273264879231027070642.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias